Neuraceq

Chemical Nameflorbetaben F 18
Dosage FormInjection (intravenous; 50 to 5000 MBq/mL (1.4 to135 mCi/mL))
Drug ClassRadioactive diagnostic agents
SystemNervous
CompanyLife Molecular Imaging
Approval Year2014

Indication

  • For positron emission tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.
Last updated on 11/14/2022

More on this drug: Clinical Trials

Document TitleYearSource
Neuraceq (florbetaben F 18) Prescribing Information.2021Life Molecular Imaging Ltd., Warwick, United Kingdom